PHS
NCNA

PFM Health Sciences’s NuCana NCNA Stock Holding History

PFM Health Sciences’s Portfolio NCNA Stock Details NCNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-89
Closed -$6.49M – 108
2018
Q4 		$6.49M Buy
89
+11
+14% +$975K 0.17% 76
2018
Q3 		$9.7M Sell
78
-6
-7% -$707K 0.14% 104
2018
Q2 		$7.99M Sell
84
-5
-6% -$616K 0.13% 104
2018
Q1 		$8.46M Buy
+89
New +$8.45M 0.17% 82

Other funds holding NCNA

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AI
Atom Investors Austin, Texas $1.12B AUM 38.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SB
Suntrust Banks Atlanta, Georgia $19.2B AUM 13.68% 1-Year Est. Return

PFM Health Sciences's NCNA Position: Q1 2019 in Review

PFM Health Sciences sold out of NuCana (NCNA) in Q1 2019, closing a stake of 89 shares — an estimated $6.49M sold.

PFM Health Sciences first reported a position in NCNA in Q1 2018 and held it in 4 quarters. The position peaked at $9.7M in Q3 2018. 13 funds tracked by Wall St. Rank hold NCNA as of Q1 2019.

  • PFM Health Sciences reported no remaining NuCana position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 89 NuCana shares in Q1 2019, an estimated $6.49M.
  • PFM Health Sciences first reported a position in NuCana in Q1 2018 and held it in 4 quarters.
  • PFM Health Sciences's NuCana position peaked at $9.7M in Q3 2018.
  • 13 funds tracked by Wall St. Rank held NuCana as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.